Analysis of high-throughput sequencing data from thousands of cancer samples has shown that cancer is closely associated with abnormal circadian clocks, as well as global activation of the immune inhibitory molecules PD-L1 and cytotoxic T lymphocyte antigen 4 ligand CTLA-4, anergy and exhaustion of T cells [161]. This evidence concerns the gene CTLA4 and cancer.